Low clinical adoption of tumor genomic profiling: cause for concern?

Michael W. DrazerDepartment of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, IL, USA; ;Department of Human Genetics, University of Chicago, IL, USA;

Randy F. SweisDepartment of Medicine, Section of Hematology/Oncology, Comprehensive Cancer Center, University of Chicago, IL, USA; ;Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL, USACorrespondence[email protected]

Click to increase image sizeClick to decrease image size

Transparency

Declaration of funding

Supported by NIH K12CA139160 (R.F.S), AACR # 16-40-15-SWEIS (R.F.S.), 2017 ASCO-Conquer Cancer Foundation - Young Investigator Award (R.F.S). MWD is funded by a Physician Scientist Training Award from the Damon Runyon Cancer Research Foundation.

Declaration of financial/other relationships

The authors have no other relationships to disclose. JME peer reviewers on this manuscript have no relevant financial or other relationships to disclose.

Acknowledgements

None reported.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Low clinical adoption of tumor genomic profiling: cause for concern?

Declaration of funding

Declaration of financial/other relationships

Information for

Open access

Opportunities

Help and information

Low clinical adoption of tumor genomic profiling: cause for concern?

Transparency

Declaration of funding

Declaration of financial/other relationships

Acknowledgements

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature